| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | 0.036 | 0.8 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |